149 related articles for article (PubMed ID: 6107333)
1. Quantitative dissection of human brain areas: relevance to transmitter analyses.
Wuketich S; Riederer P; Jellinger K; Ambrozi L
J Neural Transm Suppl; 1980; (16):53-67. PubMed ID: 6107333
[No Abstract] [Full Text] [Related]
2. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
Marsden CD
Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
[No Abstract] [Full Text] [Related]
3. Nutrition and transmitter amines in rat brain.
Nutr Rev; 1977 Oct; 35(10):283-5. PubMed ID: 21365
[No Abstract] [Full Text] [Related]
4. [Biochemicals and their functions in the brain--glucose, and amino acid and amine neurotransmitters].
Kashiwamata S; Semba R; Aoki E
No To Shinkei; 1989 Sep; 41(9):851-61. PubMed ID: 2574048
[No Abstract] [Full Text] [Related]
5. Monoamines and ischemia. Minireview.
Calderini G
Pharmacol Res Commun; 1980 Jun; 12(6):587-91. PubMed ID: 6105680
[No Abstract] [Full Text] [Related]
6. Role of biogenic amines in tetanus.
Dastur FD; Prabhu G; Nair KG; Sheth UK
J Assoc Physicians India; 1981 Mar; 29(3):211-7. PubMed ID: 6115850
[No Abstract] [Full Text] [Related]
7. Monoamines and their metabolites in Huntington's disease brain: evidence for decreased catechol-O-methyltransferase activity.
McGeer EG; Kremer B; Hayden MR
Biol Psychiatry; 1993 Apr; 33(7):551-3. PubMed ID: 8099814
[No Abstract] [Full Text] [Related]
8. Dietary amino acid precursors: effects on central monoamines, aggression, and locomotor activity in the mouse.
Thurmond JB; Kramarcy NR; Lasley SM; Brown JW
Pharmacol Biochem Behav; 1980 Apr; 12(4):525-32. PubMed ID: 6104821
[No Abstract] [Full Text] [Related]
9. Transmitter receptor alterations in Parkinson's disease.
Calne DB; Stoessl AJ
Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
[No Abstract] [Full Text] [Related]
10. Neuropharmacology and aging.
Horita A
Adv Exp Med Biol; 1978; 97():171-85. PubMed ID: 25574
[TBL] [Abstract][Full Text] [Related]
11. Amine accumulation in Parkinson's disease and other disorders.
Willis GL
Neurosci Biobehav Rev; 1987; 11(1):97-105. PubMed ID: 2952907
[TBL] [Abstract][Full Text] [Related]
12. [Parkinson disease].
Lauschke HP; Thieme F
Z Arztl Fortbild (Jena); 1981 Aug; 75(15):681-5. PubMed ID: 6125059
[No Abstract] [Full Text] [Related]
13. [Biological markers of depression].
Landowski J
Psychiatr Pol; 1987; 21(3):180-9. PubMed ID: 2892219
[No Abstract] [Full Text] [Related]
14. [Certain neurochemical aspects of the metabolism of hormones and mediators (development of a single concept].
Utevskiĭ AM; Osinskaia VO
Vopr Biokhim Mozga; 1978; 13():260-6. PubMed ID: 41365
[No Abstract] [Full Text] [Related]
15. Brain monoamines and Parkinsonism.
Hornykiewicz O
Psychopharmacol Bull; 1975 Jul; 11(3):34-5. PubMed ID: 1153656
[No Abstract] [Full Text] [Related]
16. Compartmentation of synaptic vesicles in autonomic neurons: morphological correlates of neurotransmitter pools in monoaminergic synapses; the vesicles as dual quantal elements in transmitter storage and release.
Pellegrino de Iraldi A
Adv Biochem Psychopharmacol; 1980; 25():255-68. PubMed ID: 6108683
[No Abstract] [Full Text] [Related]
17. The properties and potential function of some brain trace amines.
Boulton AA
Prog Clin Biol Res; 1980; 39():291-303. PubMed ID: 6105673
[No Abstract] [Full Text] [Related]
18. Advances in medical genetics: Huntington disease.
Hecht F
Pediatr Rev; 1987 Jul; 9(1):13-4. PubMed ID: 2902605
[No Abstract] [Full Text] [Related]
19. [Neurotransmitter abnormalities in the dementia of Alzheimer type].
Sasaki H; Arai H
Rinsho Shinkeigaku; 1986 Dec; 26(12):1290-3. PubMed ID: 2881639
[No Abstract] [Full Text] [Related]
20. Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease.
Paul R; Choudhury A; Chandra Boruah D; Devi R; Bhattacharya P; Choudhury MD; Borah A
Neurochem Int; 2017 Sep; 108():15-26. PubMed ID: 28167224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
